Hit enter to search or ESC to close
Cortexyme
  • Home
  • Team
  • Pipeline
  • Science
  • News
  • Investors
  • Careers
Cortexyme
Tag

GAIN trial

NewsPress Release

Cortexyme Announces Pipeline Update and Anticipated 2021 Milestones

By admin | News, Press Release
EventsPress Release

Cortexyme’s Phase 2/3 GAIN Trial of Atuzaginstat (COR388) in Patients with Alzheimer’s Disease Successfully Advances Past Interim Analysis

By admin | Events, Press Release
Press Release

Cortexyme Announces GAIN Trial of Atuzaginstat in Alzheimer’s Disease Has Exceeded Study Enrollment Target of 570 Patients

By admin | Press Release
EventsPress Release

Cortexyme Announces Oral Presentation on COR388 at Clinical Trials on Alzheimer’s Disease 2019

By admin | Events, Press Release
News

Bloomberg: Small Biotech Cortexyme Briefly Doubles in Red-Hot Trading Debut

By admin | News
NewsPress Release

Cortexyme Announces Phase 2/3 Clinical Trial Based on Transformational Understanding of Alzheimer’s Disease

By admin | News, Press Release

Please note our Privacy Policy and Terms of Use. ©2022 Cortexyme

  • Home
  • Team
  • Pipeline
  • Science
  • News
  • Investors
  • Careers